Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches

J Nucl Cardiol. 2020 Oct;27(5):1808-1815. doi: 10.1007/s12350-020-02205-1. Epub 2020 May 31.

Abstract

Background: ATTR cardiac amyloidosis (CA) can be diagnosed with Tc-99m-PYP scintigraphy. There are two recommended interpretative approaches: the quantitative heart-to-contralateral lung ratio (H/CL) at 1 hour and the semi-quantitative visual system at 3 hours. This study's aim was to compare both approaches and to apply the semi-quantitative method at 1 hour.

Methods: Tc-99m-PYP scans of 122 consecutive subjects were reviewed using both approaches. On 1 hour planar images, regions of interest were drawn over the heart and contralateral chest to determine H/CL. Myocardial uptake was graded on 1 and 3 hour SPECT images according to the semi-quantitative method. Concordance was examined using kappa statistics.

Results: 31, 10, and 81 studies were positive, negative, and equivocal, respectively, for ATTR-CA using the H/CL approach. Using the grading system, 35, 77, and 10 scans were positive, negative, and equivocal, respectively. The quantitative approach led to a significantly higher proportion of equivocal studies compared to the semi-quantitative approach (P < .0001). These approaches yielded discordant results in 2 subjects; biopsy results were concordant with SPECT grade. 1 and 3 hour SPECT grades provided concordant result in 99% of cases.

Conclusions: The H/CL approach resulted in a high proportion of equivocal studies. Using SPECT imaging, the semi-quantitative approach minimized this proportion and showed high concordance at 1 and 3 hours.

Keywords: 99m-Tc-pyrophosphate scintigraphy; Cardiac amyloidosis; SPECT imaging; cardiovascular imaging.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyloid Neuropathies, Familial / complications
  • Amyloid Neuropathies, Familial / diagnostic imaging*
  • Cardiomyopathies / diagnostic imaging*
  • Cardiomyopathies / etiology
  • Cardiomyopathies / metabolism
  • Female
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Radiopharmaceuticals / pharmacokinetics*
  • Retrospective Studies
  • Technetium Tc 99m Pyrophosphate / pharmacokinetics*
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Pyrophosphate

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related